课题基金 / 基金详情

项目摘要

项目成果

MICHAEL R GREEN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):程序性细胞死亡,即细胞凋亡,是正常生理以及癌症发生和治疗的关键方面。某些凋亡途径是转录调控的;在这些情况下,细胞凋亡是由编码促凋亡蛋白的基因转录激活而诱导的。这一应用主要集中在我们实验室发现并在过去几年中一直在研究的24p3/24p3R转录调控的促凋亡途径。我们最初确定24p3是在细胞因子剥夺白介素3(IL-3)依赖的细胞诱导细胞凋亡后,经历最大转录刺激的基因。24p3是一种分泌型Lipocalin,我们已发现它与多种淋巴样细胞结合后可诱导细胞凋亡。这些和其他结果揭示了一种模型,在该模型中,IL-3缺乏激活24p3转录,导致24p3的合成和分泌,24p3通过自分泌/旁分泌途径诱导细胞凋亡。我们已经分离了24p3细胞表面受体(24p3R),并发现24p3通过一种新的途径诱导细胞凋亡,最终导致细胞内铁水平下降。细胞内铁的减少诱导促凋亡蛋白Bim的表达,从而导致细胞凋亡。细胞内的铁输送阻断了BIM的诱导,并抑制了24p3添加或IL-3剥夺引起的细胞凋亡。在这一应用中,我们建议使用细胞系、患者样本和动物模型来研究24p3/24p3R促凋亡通路在正常生理和骨髓增生性疾病中的作用。细胞内铁减少诱导细胞凋亡的基础尚不清楚。我们将继续研究24p3和铁络合剂诱导的细胞凋亡途径。表达谱分析和RNA干扰将被用来识别参与24p3和铁络合剂介导的细胞凋亡的转录激活基因。我们的初步结果提示,24p3/24p3R通路可能在糖皮质激素介导的细胞凋亡和糖皮质激素耐药中发挥作用,我们将继续研究这一点。我们发现bcr-abl癌蛋白通过错误调节24p3和24p3R的表达来抵消24p3/24p3R促凋亡途径。这些结果揭示了BCR-ABL促进细胞存活机制的一个新的和意想不到的方面。我们将继续分析这一结果的普遍性,并研究24p3和24p3R转录被错误调控的基础。我们已经获得了24p3纯合子基因敲除小鼠,将用于研究24p3/24p3R促凋亡通路在bcr/abl诱导的骨髓增生性疾病中的作用。
英文摘要
DESCRIPTION (provided by applicant): Programmed cell death, apoptosis, is a critical aspect of normal physiology as well as the genesis and treatment of cancer. Certain apoptotic pathways are transcriptionally regulated; in these cases, apoptosis is induced by the transcriptional activation of genes encoding proapoptotic proteins. This application focuses on the 24p3/24p3R transcriptionally-regulated proapoptotic pathway that our laboratory discovered and has been studying for the past several years. We originally identified 24p3 as the gene undergoing maximum transcriptional stimulation following induction of apoptosis by cytokine-deprivation of interleukin 3 (IL-3) dependent cells. 24p3 is a secreted lipocalin, which we have found induces apoptosis when added to a variety of lymphoid cells. These and other results revealed a model in which IL-3 deprivation activates 24p3 transcription, leading to synthesis and secretion of 24p3, which induces apoptosis through an autocrine/paracrine pathway. We have isolated the 24p3 cell surface receptor (24p3R) and found that 24p3 induces apoptosis through a novel pathway culminating in a decrease in intracellular iron levels. The decrease in intracellular iron induces expression of the proapoptotic protein Bim, resulting in apoptosis. Intracellular iron delivery blocks induction of Bim and suppresses apoptosis due to 24p3 addition or IL-3 deprivation. In this application we propose experiments to study the role of the 24p3/24p3R proapoptotic pathway in normal physiology and myeloproliferative disease using cell lines, patient samples and animal models. The basis by which decreased intracellular iron induces apoptosis is not well understood. We will continue to characterize the apoptotic pathway induced by 24p3 and by iron chelators. Expression profiling and RNA interference will be used to identify transcriptionally activated genes involved in 24p3- and iron chelator-mediated apoptosis. Our preliminary results suggest a possible role for the 24p3/24p3R pathway in glucocorticoid-mediated apoptosis and glucocorticoid-resistance, which we will continue to investigate. We have found that the BCR-ABL oncoprotein counteracts the 24p3/24p3R proapoptotic pathway by misregulating expression of 24p3 and 24p3R. These results reveal a new and unanticipated aspect of the mechanism by which BCR-ABL promotes cell survival. We will continue to analyze the generality of this result and study the basis by which 24p3 and 24p3R transcription is misregulated. We have derived 24p3 homozygous knockout mice, which will be used to study the contribution of the 24p3/24p3R proapoptotic pathway to BCR/ABL-induced myeloproliferative disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transcriptional Upregulation of the Epigenetically Repressed FXN Gene as a Therapeutic Approach for Friedreich Ataxia
Transcriptional Upregulation of the Epigenetically Repressed FXN Gene as a Therapeutic Approach for Friedreich Ataxia
A Novel Druggable Epigenetic Vulnerability Pathway in HCC
A Novel Druggable Epigenetic Vulnerability Pathway in HCC
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: